Maxolon to Improve Breastmilk Supply in Diabetic Women: a Randomised Controlled Trial
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
Early use of oral maxalon can hasten and improve the establishment of breastfeeding in
diabetic mothers after preterm and term deliveries.
Maxolon promotes breastfeeding by working on the central nervous system which increases the
milk producing hormone, prolactin which in turn helps to increase the milk supply for
breastfeeding. Successful early breastfeeding establishment is important for continued
breastfeeding.